Thrombotic RIsk FActors in AL-goneurodystrophy

N/AEnrolling By InvitationNCT07435207

Fondazione IRCCS Policlinico San Matteo di Pavia120 enrolled

Overview

The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Algoneurodystrophy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria:Clinical (according to Budapest clinical diagnostic criteria for CRPS) * patients aged 18 years or more Exclusion Criteria:patients unable to give consent \-

Locations (1)

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, Pavia, Italy

Outcomes

Primary Outcomes

Pain VAS

change in Pain VAS

Time frame: 1,3 and 6 months after therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.